Patents-Review.com
ClassID:

97118 ⎘

C07K16/1072 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus; Retroviridae, e.g. leukemia viruses; Lentiviridae, e.g. HIV, FIV, SIV Regulatory proteins, e.g. tat, rev, vpt

Recent Application in this class:
#1
20240182550
2024-06-06

ANTIBODIES, FRAGMENTS OR DERIVATIVES SPECIFICALLY BINDING TO A PROTEIN ANTIGEN CAPABLE OF BINDING TO NUCLEIC ACIDS AND USES OF SAME

 #2
20230061973
2023-03-02

TAT PEPTIDE BINDING PROTEINS AND USES THEREOF

 #3
20200331990
2020-10-22

MOBILIZING HIV-INFECTED CELLS FROM LYMPHATIC RESERVOIRS

 #4
20200182883
2020-06-11

Methods of making active antibodies from biological fluids

 #5
20190314503
2019-10-17

Single domain antibodies directed against arachidonate 12-lipoxygenase

 #6
20190038760
2019-02-07

CO-ADMINISTRATION OF AN AGENT LINKED TO AN INTERNALIZATION PEPTIDE WITH AN ANTI-INFLAMMATORY

 #7
20190010217
2019-01-10

MOBILIZING HIV-INFECTED CELLS FROM LYMPHATIC RESERVOIRS

 #8
20180327782
2018-11-15

LENTIVIRAL VECTORS AND USES THEREOF

 #9
20180298359
2018-10-18

Intracellular protein delivery

 #10
20170043030
2017-02-16

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

 #11
20150191710
2015-07-09

Intracellular protein delivery

 #12
20150158933
2015-06-11

HIV antigens and antibodies and compositions, uses and methods thereof

 #13
20150094226
2015-04-02

Crystal Structure of a NEF/SdAb19 Complex and Uses Thereof

 #14
20130164250
2013-06-27

Bioresorbable nonlamellar microparticles and uses thereof

 #15
20120252731
2012-10-04

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

 #16
20120214151
2012-08-23

Detection of HIV-related proteins in urine

 #17
20120208175
2012-08-16

Detection of HIV-related proteins in urine

 #18
20120201811
2012-08-09

GENERATION AND USE OF FAB, SCFV, AND RELATED BINDING MOLECULES SPECIFIC FOR HIV-1 REV

 #19
20110318377
2011-12-29

Screening method for the identification of inhibitors of HIV Tat methylation by the lysine methyltransferase Set7/9

 #20
20100303834
2010-12-02

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

 #21
20100086956
2010-04-08

Detection of HIV-related proteins in urine

 #22
20090233267
2009-09-17

Methylated tat polypeptides and methods of use thereof

 #23
20080293036
2008-11-27

Monoclonal antibodies to HIV-1 and methods of using same

 #24
20080241259
2008-10-02

Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof

 #25
20080124331
2008-05-29

Anti-TAT188 antibodies

 #26
20070098741
2007-05-03

Vectors derived from antibodies for transferring substances into cells

 #27
20070059681
2007-03-15

Method for production of bioresorable microparticles, microparticles thus obtained and use thereof

 #28
20060258594
2006-11-16

Methods and compositions for impairing multiplication of HIV-1

 #29
20060240028
2006-10-26

Anti-nls substances and uses thereof in nuclear import inhibition

 #30
20060211108
2006-09-21

Methods and compositions for impairing multiplication of HIV-1

 #31
20060205070
2006-09-14

HIV TEV compositions and methods of use

 #32
20060153862
2006-07-13

Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

 #33
20060147997
2006-07-06

PenetraBodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases

 #34
20060104988
2006-05-18

Vaccines against hiv-1 tat protein to generate neutralizing antibodies

 #35
20060019395
2006-01-26

Lentiviral vectors and uses thereof

 #36
20050245454
2005-11-03

Methods and compositions for impairing multiplication of HIV-1

 #37
20050106644
2005-05-19

Antibody compositions for the diagnosis and treatment of tumor